What is HC Wainwright’s Estimate for Insmed Q1 Earnings?
Insmed Incorporated (NASDAQ:INSM – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of Insmed in a research report issued to clients and investors on Friday, February 21st. HC Wainwright analyst A. Fein forecasts that the biopharmaceutical company will earn ($1.47) per share for the quarter. HC Wainwright […]
